Brief: Atossa Therapeutics Inc To Acquire Stake In Privately Held Dynamic Cell Therapies
01/11/2022 13:46
Nov 1 (Reuters) - Atossa Therapeutics Inc ATOS.O :
* ATOSSA THERAPEUTICS, INC. TO ACQUIRE STAKE IN PRIVATELY
HELD
DYNAMIC CELL THERAPIES AS PART OF OVERALL CAR-T STRATEGY
* ATOSSA THERAPEUTICS - WILL ACQUIRE SHARES EQUAL TO 19.99%
OF
OUTSTANDING CAPITAL STOCK OF DCT AS OF TODAY FOR A CASH PAYMENT
OF $2 MILLION
Source text for Eikon: ID:nGNXYbJwp
Further company coverage: ATOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary